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Background: Low physical activity is a major public health problem. New cost-effective approaches that stimulate
meaningful long-term changes in physical activity are required, especially within primary care settings. It is becoming
clear that there are various dimensions to physical activity with independent health benefits. Advances in
technology mean that it is now possible to generate multidimensional physical activity ‘profiles’ that provide
a more complete representation of physical activity and offer a variety of options that can be tailored to the
individual. Mi-PACT is a randomised controlled trial designed to examine whether personalised multidimensional physical
activity feedback and self-monitoring alongside trainer-supportive sessions increases physical activity and improves health
outcomes in at-risk men and women.
Methods/Design: We aim to recruit 216 patients from within primary care aged 40 to 70 years and at medium or high
risk of cardiovascular disease and/or type II diabetes mellitus. Adopting an unequal allocation ratio (intervention: control)
of 2:1, participants will be randomised to one of two groups, usual care or the intervention. The control group will receive
usual care from their general practitioner (GP) and standardised messages about physical activity for health.
The intervention group will receive physical activity monitors and access to a web-based platform for a 3-month
period to enable self-monitoring and the provision of personalised feedback regarding the multidimensional nature of
physical activity. In addition, this technology-enabled feedback will be discussed with participants on 5 occasions
during supportive one-to-one coaching sessions across the 3-month intervention. The primary outcome measure is
physical activity, which will be directly assessed using activity monitors for a 7-day period at baseline, post intervention
and at 12 months. Secondary measures (at these time-points) include weight loss, fat mass, and markers of metabolic
control, motivation and well-being.
Discussion: Results from this study will provide insight into the effects of integrated physical activity profiling and
self-monitoring combined with in-person support on physical activity and health outcomes in patients at risk of
future chronic disease.
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Physical inactivity has substantial effects on global health
and an increase in activity at the population level would
have considerable impact on the future burden of chronic
disease [1]. In the United Kingdom, the Department of
Health recently began a national programme (NHS Health
Check) that aims to reduce chronic disease by identifying
adults who are at increased risk and offering them perso-
nalised advice and support to lower their risk [2]. Physical
activity has the potential to increase the success of such
initiatives, but existing interventions in primary care have
met with limited success and typically small improve-
ments are not maintained [3]. New cost-effective ap-
proaches that stimulate meaningful long-term changes in
physical activity are required and this is especially import-
ant in those identified as at risk of cardiovascular disease
and type II diabetes mellitus.
To date, physical activity has typically been captured
and recommended in unidimensional terms (e.g. 150 mi-
nutes of moderate intensity physical activity per week) [4].
Physical activity is a much more heterogeneous behaviour
than this approach implies, with various dimensions
known to have clear biological and health benefits [5]. In-
deed, past work shows that it is quite possible for an indi-
vidual to score highly in one dimension of physical activity
but low in another, while only very few people score con-
sistently across all physical activity metrics [6]. This obser-
vation is a problem because people who focus on a single
physical activity descriptor may form incomplete or in-
accurate conclusions about the appropriateness of their
behaviour. For example, many forms of structured phys-
ical activity have only a modest impact on overall energy
expenditure [7]. Weight loss is critical to some health out-
comes, or an outcome in itself, and it will be important
for individuals aiming to lose weight (or prevent weight
regain after substantial loss) to understand which aspects
of physical activity have the largest thermogenic effect. In
this specific scenario, a multidimensional approach will
help people incorporate novel activity within the context
of their existing behaviour such that the net effect on total
energy expenditure is maximised [7, 8]. Clearly, a multidi-
mensional profile will provide greater insight, awareness,
and deeper understanding than the reliance on more uni-
dimensional feedback; enabling people to take greater re-
sponsibility for managing their physical activity.
In addition to providing a more accurate reflection of
physical activity, the diverse options associated with a
multidimensional physical activity profile create an ex-
ploitable social marketing opportunity. The marketing of
structured and informational feedback and the provision
of personally relevant and attainable physical activity op-
tions is potentially a key step in supporting an individ-
ual’s satisfaction of autonomy and competence [9, 10].
When people experience a sense of self-endorsed andchoicefully enacted behaviour this tends to improve the
quality of their motivation and sustain engagement in
physical activity [9, 10]. Indeed, the provision of more
comprehensive and revealing feedback on behaviour
should also raise awareness and support the formation of
implementation intentions (i.e. where, when and how to
act); increasing goal attainment and habit formation [11].
New technologies, which include wearable devices and
web-based applications, enable self-monitoring of phys-
ical activity and create opportunities for the provision of
personalised feedback regarding the multidimensional
nature of physical activity [5]. This type of individually
tailored feedback tends to be more effective than generic
messages about physical activity [12, 13]. Moreover,
feedback and self-monitoring in combination with spe-
cific goal setting are acknowledged as key constituents
of successful behavioural interventions [14–16]. In order
to exploit the opportunities for physical activity monitor-
ing and multidimensional physical activity profiling, we
developed a website-based application for linking phys-
ical activity data with informational feedback; creating
an interface for self-monitoring, specific planning and
trainer interaction, that collectively forms the basis for
the present trial. This was informed by prior work, in
which we generated visualisations for the presentation of
integrated physical activity profiles and demonstrated
that patients at medium or high risk of chronic disease
found this feedback to be informative, understandable
and motivating [17]. In addition, while patients reported
feeling confident in using technology and feedback for
self-monitoring physical activity, it was identified that
supplementary in-person guidance may further support
behaviour change.
The Multidimensional individualised Physical ACTivity
(Mi-PACT) study is a randomised controlled trial with the
following objectives: (1) to examine whether personalised
multidimensional physical activity feedback and self-
monitoring using a web-based platform alongside in-
person advice supports an increase in physical activity in
men and women at risk of future chronic disease; and (2)
to examine whether this change is sufficient to generate
meaningful weight loss and/or improved metabolic con-
trol and reduced risk.
Methods
Trial design
In Mi-PACT, patients at risk of cardiovascular disease or
type II diabetes mellitus are randomly assigned to receive
usual care (control group) or technology-enabled multidi-
mensional physical activity feedback (intervention group).
Figure 1 illustrates the course of progress through the
study consistent with current Consolidated Standards of
Reporting Trials (CONSORT) guidelines for reporting
randomised trials [18]. The trial described herein was
Fig. 1 Flow of participants through the study. Patients identified as ‘at risk’ and who volunteer will be assessed for eligibility via telephone screen
and attendance at a baseline assessment clinic. Eligible people will be randomised to either the control (usual care) or intervention (Mi-PACT) group by
concealed minimisation. Follow-up assessments will take place post intervention at 3 and 12 months
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South West 3 Research Ethics Committee with an
allocated reference number: 13/SW/0179. The pro-
ject was subsequently registered as a current con-
trolled trial (ISRCTN18008011).
Participants/eligibility
We will recruit men and women treated in primary care
aged 40–70 years at medium (≥10 and < 20 %) or high
(≥20 %) risk of cardiovascular disease and/or type II dia-
betes mellitus. Risk will be calculated from clinical data
using well-established prediction algorithms for estimating
a person’s 10-year risk of developing cardiovascular disease
(QRISK®2) [19] and diabetes mellitus (QDiabetes®) [20]
available at QResearch® [21]. As our focus is on prevention,
people with existing coronary heart disease, chronic kidney
disease (stages 3–5), diabetes mellitus, stroke, heart failure
and peripheral arterial disease (as they will be managed viaexisting care pathways) will be excluded. The Physical Ac-
tivity Level (PAL) is a standard objective method of ex-
pressing total daily energy expenditure in multiples of
resting metabolic rate. Individuals will be excluded with an
average daily PAL > 2.0, which has been categorised in a re-
port of a joint FAO/WHO/UNU expert consultation as
representing a highly active lifestyle [22]. In addition, indi-
viduals will be excluded for whom sufficient baseline phys-
ical activity data is not available. To be eligible, individuals
will need at least 6 valid monitoring days (including both a
Saturday and Sunday) [23]. A valid day will require at least
80 % of data for a given 24-hour period. See Table 1 for a
complete list of eligibility criteria.
Study procedures
Recruitment
Patients will be recruited in Bath and North East Somerset
and Wiltshire. We aim to recruit at least five general
Table 1 Inclusion and exclusion criteria for Mi-PACT
Inclusion criteria
• Able to give informed consent to participate in the study
• Aged between 40–70 years
• Recruited from within primary care
• At medium (≥10 and < 20 %) or high (≥20 %) risk of cardiovascular
disease and/or type II diabetes mellitus
Exclusion criteria
• People with existing coronary heart disease, chronic kidney disease,
(stages 3–5), diabetes mellitus, stroke, heart failure and peripheral
arterial disease
• Resting blood pressure greater than 180/100 mmHg
• Body mass index greater than 40 kg/m2
• Currently pregnant
• Currently taking any medications that may affect weight loss
• Not fluent in English
• Currently participating in another research trial or lifestyle supportive
intervention
• People reporting a recent (in the last 6 months) shift (>5 %) in body
mass or large change in habitual lifestyle
• Individuals unable to change their physical activity (e.g. through
disability) or individuals who already lead highly physically active
lifestyles (PAL > 2.0)
• Insufficient baseline physical activity data (<6 valid monitoring days
including a Saturday and Sunday)
• People with terminal illness and anyone who, in their general
practitioner’s opinion, has other co-morbidities which would prevent
engagement with the intervention
PAL Physical Activity Level
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cording to National General Practice Profiles and the Eng-
lish Indices of Deprivation [24, 25]. We will recruit
potentially eligible participants via two routes. Firstly, indi-
viduals in medium or high-risk groups (based on existing
risk-score information in patient notes) will be identified
by searching practice databases. Secondly, because not all
people will have risk information in their records, individ-
uals at potentially increased risk will be identified (people
with a body mass index (BMI) > 30 kg/m2 in combination
with a total cholesterol level between 5.5 and 7.5 mmol/L
and/or blood pressure > 140/90 mmHg). This is consistent
with Health Check criteria, and clinical data from baseline
assessments will be used to verify that individuals are in
medium or high-risk groups, using QRISK®2 and QDia-
betes® algorithms [19, 20]. Potentially eligible participants
will then be approached by a letter from their general
practitioner (GP). The recruitment letter will emphasise
that participation is entirely voluntary and that individuals
will be free to withdraw at any time without any impact
on their health care provision. A study information sheet
and sample consent form will be included with the letter
so that patients have time to consider their participation.
The invitation letter will include a free post reply slip forthe patient to return to the research team indicating
whether or not they wish to learn more about the study.
Individuals who return positive replies will then be con-
tacted by the research team. Those not wishing to partici-
pate will not be contacted again.
Participant screening and baseline assessment
A research nurse will first conduct a telephone screen to
re-confirm eligibility. In addition, information regarding
marital status, ethnicity, smoking status, profession and
education will be recorded. All potentially eligible partic-
ipants interested in taking part will be invited to attend
a 60-minute baseline assessment clinic following an
overnight fast. At baseline clinics, the research nurse will
further explain the nature of the study and answer any
questions. Individuals who agree to participate following
the briefing will be provided with an informed consent
form, indicating their full understanding of the study
and their protected rights for confidentiality and with-
drawal from the study without giving a reason. For those
providing written informed consent, concomitant medi-
cations and relevant clinical history will be recorded and
a questionnaire pack will be issued for completion
within clinic. Thereafter, the nurse or researcher will
measure each individual’s blood pressure, weight, height,
waist circumference and take a blood sample. During
the clinic, individuals will receive an activity monitor
with oral and written instruction for use and will be pro-
vided with a freepost envelope for returning monitors to
the research team. For those participants who choose to
opt-in, a visit to the University of Bath will be arranged
for the assessment of body composition via dual energy
X-ray absorptiometry. Blood results will be shared with
each patient’s GP. Patients with a fasting blood glucose
of > 7.0 mmol/l at this stage will be excluded from fur-
ther participation as this will likely initiate further test-
ing by the GP and is indicative of probable diabetes
mellitus. People successfully completing activity moni-
toring who are not highly physically active and are in
medium-risk or high-risk groups (confirmed via recalcu-
lated risk scores using baseline measurements and the
results of blood tests) will be eligible for randomisation.
Randomisation/allocation
Eligible people will be randomised to one of two groups.
We opt for an unequal allocation ratio (intervention:
control) of 2:1, primarily to increase our experience with
and amount of information on the new intervention [26]
(the small loss of precision with unequal allocation only
increases the total N required by 20). Participants will be
allocated remotely by the trial statistician by concealed
minimisation [27], providing balance across the trial arms
for sex (male/female), age group (40–59 and 60–70 years),
general practice, risk (medium/high) and PAL < 1.75 or ≥
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isation, we believe that the threat of contamination within
a practice is largely theoretical, especially given that the
intervention is personalised.
Follow-up assessment
Follow-up data collection will take place post-intervention
at 3 and 12 months and will include the same measure-
ments completed during baseline assessment. Participants
who opt-in for the assessment of their body composition
at baseline will be offered repeat dual-energy X-ray ab-
sorptiometry scans at follow-up clinics. Participants will
receive a £50 voucher for completing all assessments.
Usual care (control)
Participants allocated to the control group will receive
usual care by their GP. Any care that they receive in rela-
tion to supporting changes in weight or physical activity
will be documented through self-report and examination
of practice records at assessment clinics. Hence, the trial
will assess effectiveness over-and-above existing ‘usual
care’ alternatives. In order to standardise exposure to
healthcare professionals and content, this group will attend
a 20-minute meeting with a lifestyle coach at their GP
practice following their baseline assessment (i.e. week 0).
At this session, participants will receive standardised infor-
mation (including printed materials and links to Internet-
based resources) regarding cardiovascular disease and type
II diabetes mellitus, the potential benefits of physical activ-
ity on reducing ‘risk’, current physical activity guidelines
and ideas about getting more physically active. Standar-
dised information and messages will be consistent with
other print and Internet-based resources available in 2014
(for example, Department of Health: Change4Life [28],
NHS Choices: Live Well [29]) and include reference to
local opportunities where applicable.
Intervention: overview
Mi-PACT is a complex intervention or ‘treatment package’
involving multiple components [30]. The intervention con-
tent and iterative web-based platform was developed by
the project team and drew heavily on our formative re-
search involving the generation of novel integrated phys-
ical activity profiles [4, 6]. The content was further
informed by our prior qualitative research with healthcare
professionals and patients at risk of future chronic disease
(reflecting the intended user group) in the development
and evaluation of innovative ways of presenting per-
sonalised multidimensional physical activity feedback
that is informative, understandable and motivating [17].
The intervention is described in accordance with TIDieR
(Template for Intervention Description and Replication)
guidance relevant to protocols of trials [31].Intervention: overarching theoretical framework
Social marketing represents an attractively designed
‘customer proposition’ that has been developed and
communicated using marketing principles to align with
the self-interests of participants and in exchange for be-
haviour which benefits them and society as a whole
[32]. This is where a multidimensional physical activity
profile creates a clear social marketing opportunity. In-
deed, the marketing of structured and informational feed-
back coupled with a menu of achievable physical activity
options may facilitate greater empowerment (or autono-
mous engagement) via support of an individual’s satisfac-
tion of autonomy and competence [9]. When people
experience autonomy and competence in their treatment,
they experience greater volitional engagement and are
more likely to persist in desirable health behaviours
[9, 10]. In promoting the formation of new habits, imple-
mentation intentions are specific plans regarding where,
when, and how to act, and have been found to increase goal
attainment [11] and predict participation in physical activity
[33]. A multidimensional profile that supports the forma-
tion of implementation intentions as feedback is more re-
vealing and plans may be considered within the context of
an individual’s existing behaviour. Indeed, the combination
of implementation intentions and autonomous behaviour
has been shown to result in greater goal achievement [34]
and represent theoretical constructs that are inherent
within the marketing of integrated physical activity profiles.
Intervention: physical activity profiling and the Mi-PACT
platform
The Mi-PACT technology consists of a Bodymedia Core
physical activity monitor (BodyMedia, Inc., Pittsburgh,
PA, USA) and a web-based application or ‘platform’ devel-
oped in collaboration with Ki Health Innovation Ltd.
(Surrey, UK) Information graphics used for the presenta-
tion of data within the web-based platform were initially
developed alongside graphic designers (Information is
Beautiful, IIB Studio, London, UK). Draft designs were
subsequently refined by the research team based upon the
findings of in-depth qualitative interviews in patient
groups and healthcare professionals [17]. Overall, patients
preferred simple messages rather than more complex or
abstract visualisations [17]. However, as there is unlikely
to be a definitive design solution to meet the needs of
everyone, and to provide some choice, the Mi-PACT plat-
form includes alternative graphical formats for displaying
the same data.
The integrated physical activity profile captures phys-
ical activity across different physiologically important
and mutually independent dimensions [6]. Data are
depicted in a simple wheel format using a traffic light
colour-coding system as an index of attainment (Fig. 2).
These data are also presented as colour-coded bars
Fig. 2 Platform screenshot displaying the integrated physical activity profile across the different physiologically-important dimensions (expressed
relative to guidelines)
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tude for each dimension. Each participant’s profile captures
5 different dimensions of their behaviour: (1) overall energy
expenditure, (2) time engaged in moderate-to-vigorous
physical activity accumulated on a minute-by-minute basis,(3) time engaged in moderate-to-vigorous physical activity
accumulated in bouts of at least 10 minutes, (4) time en-
gaged in vigorous intensity activity accumulated in bouts
of at least 10 minutes and (5) participation in non-
sedentary activity as a proportion of the waking day.
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time spent and energy expended within different inten-
sity thresholds determined using metabolic equivalentsFig. 3 Platform screenshot depicting minute-by-minute energy expenditur
thresholds (as daily or weekly summaries)(METs). These data are presented as minute-by-minute
24-hour line graphs (using a ‘heat’ colour palette) and
are summarised into daily and weekly totals (Fig. 3). Ine and both time spent and energy expended in different intensity
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specific equations are used to estimate Basal Energy Ex-
penditure [35]. Activities with a MET value below 1.8
are considered as sedentary behaviour when using this
specific monitoring technology [23, 36]. MET values
greater or equal to 1.8 and less than 3 are considered to
reflect light activity, while moderate and vigorous activ-
ities are calculated from MET values greater or equal to
3 and less than 6, and greater or equal to 6 [37]. Re-
cently, evidence has emerged that short bouts of high-
intensity exercise has profound metabolic and health
benefits, e.g. short bouts of exercise at approximately
80–90 % maximal oxygen uptake [38]. In the absence of
an accepted definition of such activity in free-living con-
ditions, we define physical activity greater or equal to
10.2 METs as ‘highly vigorous’ [6]; equivalent to approxi-
mately 85 % maximal oxygen uptake in an average per-
son [39].
In addition to providing feedback in the form of inte-
grated physical activity profiles for ‘Health’ and as ‘Activity’
within different intensity thresholds, there are reviewing
and planning components to the platform. The ‘Review’
section displays personalised minute-by-minute data (as a
greyscale silhouette to emphasise activity patterning) that
enables the individual to highlight, annotate or ‘tag’ and
store information regarding discrete activities and behav-
iours as part of the self-monitoring process (Fig. 4). This
‘tagged’ information is then available as part of an individ-
ual’s historical data and viewable/editable on subsequent
access of the platform. The ‘Plans’ section displays daily
physical activity visualisations for the week and presents
this information relative to the individual’s integrated phys-
ical activity profile (Fig. 5). In line with an implementation
intention approach, there is an opportunity for the gener-
ation of specific plans regarding where, when and how to
act. Indeed, the participant can explore the effects of ex-
changing sedentary behaviour for more positive behaviours
(selecting from their personal ‘tags’ or from a database of
activities) to realise the impact of any such substitution [8]
on a change in their physical activity profile.
Intervention: Multidimensional individualised Physical
ACTivity (Mi-PACT)
In the Mi-PACT group, feedback in the form of persona-
lised physical activity profiles will be marketed, explained
and discussed with participants in supportive one-to-one
coaching sessions using the web-based platform. Partici-
pants will attend their GP practice for 5 consultations
with a lifestyle coach: at baseline, and after approxi-
mately 2, 4, 8 and 12 weeks. Each participant will have
access to activity monitors and the web-based platform
for the duration of the 3-month intervention. Training
materials for lifestyle coaches as well as hand-outs pro-
vided to study participants are available on request [40].In the first session, participants will initially receive the
same standardised messages as in the control group. The
primary aim of this session is to explain the multidimen-
sional nature of physical activity, to provide an understand-
ing of which personalised behaviours have contributed to
each dimension and to explain the options and choices
that are available. A further objective is to familiarise the
participant to activity self-monitoring and using the web-
based platform. For this purpose, each participant will be
given a Mi-PACT platform user manual and quick-start
guide along with an activity monitor and Universal Serial
Bus (USB) cable (for docking to their computer). Partici-
pants will have access to a personalised website account
(protected by a log-in and password) and accompanying
software for uploading their physical activity data. Prior to
their next session, participants will be encouraged to ex-
periment and engage in new and enjoyable activities (i.e.
‘trying different things’) while self-monitoring and explor-
ing the functionality of the platform.
Subsequent sessions will be approximately 20–30 mi-
nutes in duration. Prior to meetings, coaches will be en-
couraged to log-in to the platform and review participants’
profiles as a preparatory exercise to help inform session
delivery. Once it is established that the participant is confi-
dently self-monitoring and reviewing their data, the aim of
the second session is to revisit the participants’ physical
activity profile and to discuss aspects of their physical ac-
tivity behaviour that they would consider changing. Here,
there will be a particular emphasis on identifying oppor-
tunities for achievable but sufficiently meaningful modifi-
cation and specific goal setting regarding what, where and
how to act. Participants who have low activity in every di-
mension have the most ‘choice’ and will be guided through
a menu of physical activity options. Participants who score
well in one or more dimensions will be supported in add-
ing to their existing behaviour knowing that what they are
doing is recognised. In terms of the tone of advice pro-
vided, coaches will attempt to use neutral language and
encourage choice (e.g. using terms such as ‘you may
choose to’ or ‘how would you’ rather than ‘you should’ or
‘you must’) and show empathy (e.g. ‘I appreciate why you
might find this difficult’). These vocalisations will be pro-
vided in a structured manner such that goals, strategies,
and implementation intentions are clear, realistic, and
well-defined [10].
The primary focus of subsequent sessions will involve
reviewing the impact of any changes and in supporting
all efforts the participant has made to be more active, as
well as recalibrating specific goals and plans within the
context of the individual’s existing behaviour and life-
style. This process will be led by the participant and will
inevitably be highly individualised. At the final session,
participants will be encouraged to consider their pro-
gress by using the multidimensional profile to reflect on
Fig. 4 Platform screenshot displaying personalised minute-by-minute energy expenditure data and accompanying platform features for
reviewing behaviour
Peacock et al. Trials  (2015) 16:381 Page 9 of 16what has been achieved and to develop a future action
plan towards long-term change.
Participants will be urged to make the most of the web-
based platform by wearing their physical activity monitor
as much as possible (day and night) and to regularly upload
their data and review their informational feedback over the3-month intervention period. As the server has two por-
tals, one for the participant and one for the research team,
technical issues (e.g. with uploading data) can be identified
and resolved by the research team. For participants without
access to a computer or the Internet, coaches will facilitate
the upload of data to the platform within session and the
Fig. 5 Platform screenshot depicting weekly activity patterns expressed relative to an individual’s multidimensional profile and features for exploring
the impact of any changes and action plans on their behavioural goal(s)
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colour print-out where applicable. Participants with limited
or no access to the platform outside of sessions will be pro-
vided with a diary for recording what aspects of their phys-
ical activity they have consciously changed between
sessions (i.e. for self-monitoring purposes).
Training of the lifestyle coaches: intervention and control
We will recruit 4–6 intervention providers from the local
community (including healthcare providers and other ap-
propriate settings) with experience and qualifications as
physical activity or lifestyle advisors. Intervention providerswill be added to the GP’s office for the intervention period
and may include registered healthcare professionals (e.g.
dieticians) and/or non-registered professionals (e.g. health
trainers). This mix of personnel is included in order to
make the study as pragmatic and generalisable as possible
to routine healthcare practice. To ensure delivery is com-
pliant to treatment protocol, we will implement a number
of strategies to maximise and monitor trial fidelity. Life-
style coaches will participant in 2 days of training, includ-
ing: (i) understanding the multidimensional nature of
physical activity, (ii) familiarising with the web-based
platform and self-monitoring technology, (iii) using
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goals and forming implementation intentions, and (iv)
provision of information in an autonomy-supportive man-
ner (facilitating the participant’s satisfaction of autonomy
and competence inherent within multidimensional profil-
ing). All coaches will be given a written manual to support
delivery of the intervention and will have the opportunity
to practice and receive feedback on delivery style and con-
tent. The manual includes reference to general information
on facilitating behaviour change adapted from the Depart-
ment for Health NHS Health Trainer Handbook [41].
Whilst sessions are not specifically founded on Self-
Determination Theory, they are designed to be delivered
in an autonomy-supportive style. Other materials to fur-
ther support delivery of and document the intervention
will be produced as required.
Measurements
The primary outcome measure is physical activity, which
will be directly assessed using physical activity monitors
(see Physical Activity Assessment) for a 7-day period at
all assessment points. We will use the underlying raw
data for minute-by-minute physical activity energy ex-
penditure to extract multiple physical activity character-
istics and determine the change in a given (multiple)
dimension(s) of physical activity behaviour. Specifically,
this includes: overall energy expenditure (expressed as
PAL); time engaged in moderate-to-vigorous physical ac-
tivity accumulated on a minute-by-minute basis and in
bouts of at least 10 minutes; time engaged in vigorous
intensity activity accumulated in bouts of at least 10 mi-
nutes; and, non-sedentary time. To explore if the change
in physical activity is meaningful, we will include sec-
ondary measures of weight, height, waist circumference,
fat mass, lipids (total cholesterol, high-density lipoprotein
and low-density lipoprotein cholesterol, and triglycerides),
glucose control (insulin and glucose) and C-reactive pro-
tein. In addition, processes of change (e.g. need satisfaction
and markers of internalisation), habit strength, motivation
(autonomous and controlled), and indices of well-being,
health status and quality of life will all be assessed. To-
gether with physical activity data, these measures will
allow us to examine whether changes in specific dimen-
sions of physical activity are more or less important for
specific outcomes (e.g. PAL, time > 3 METs). Based on
previous research, small groups of 12–20 people in each
physical activity category would be sufficient to determine
whether a change in a particular aspect of physical activity
was important for these secondary outcomes [42].
Anthropometry, blood pressure and body composition
Participants will be requested to remove any footwear
and to wear only light clothing for anthropometric mea-
surements. Body mass will be measured on a calibratedelectronic or balance scale to the nearest 0.1 kg, where
participants will be asked to stand in the centre of the
platform with their weight evenly distributed on both
feet. Height will be measured using a stadiometer to the
nearest 0.1 cm. Participants will be requested to hang
their arms freely with their heels, gluteal area and shoul-
ders in contact with the stadiometer and with their head
in the Frankfort plane (orbitale and tragion are horizon-
tally aligned). The participant inspires for measurement,
and the recorder brings down the headboard to com-
press the hair. From these collective measurements, BMI
will be determined (kg.m−2). To assess waist circumfer-
ence, participants will be asked to remove or lift their
top to allow access to the measurement site. Otherwise,
the measurement will be taken over the thinnest layer of
clothing. With the participant standing with their feet
together and weight evenly distributed, waist circumfer-
ence will be assessed by positioning an anthropometric
tape midway between the uppermost border of the iliac
crest and the lower border of the costal margin, with the
tape placed around the abdomen at the level of the mid-
way point. Following a deep inhalation and a gentle ex-
piration, the measurement is taken at the end of the
expiration, with the tape snug but not compressing the
skin. Three consecutive measurements will be made to
the nearest 0.1 mm. Blood pressure will be assessed
using a stethoscope or automated monitor after at least
a 5-minute period of seated rest. With the arm sup-
ported at the level of the heart the measurement will be
taken from the brachial artery on three consecutive oc-
casions (with the lower of the last two measurements
being recorded).
Dual energy X-ray absorptiometry
Total percentage body fat will be estimated using dual en-
ergy X-ray absorptiometry (in participants who choose to
opt-in for this measure). Descriptive information for each
participant including date of birth, height and weight will
be entered into the software (Hologic, Bedford, UK) before
they are asked to lie supine on the scanning table (Discov-
ery, Hologic, Bedford, UK). Participants will be positioned
centrally with feet equally spaced and arms with an even
gap from the trunk and asked to remain as still as possible
during the 7-minute scan. Following completion of the
scan, whole body composition analysis will be performed
with regions sectioned as recommended (Hologic, Bedford,
UK). ‘Central adipose tissue’ (abdominal subcutaneous and
visceral adipose tissue) will be estimated from a central re-
gion between L1–L4, which has previously been shown to
correlate with measures of metabolic health [43]. Follow-
ing an overnight fast, participants will be required to con-
sume 1 pint of water on waking (to ensure adequate
hydration) and to void their bladder prior to assessment.
This is important to minimise variations in hydration
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lean mass estimates [44]. In addition, participants will only
wear light clothing for the analysis. Fat mass index (FMI)
will be calculated using the equation:
FMI ¼ total fat mass kgð Þ=height2 m2 
with participants classified according to FMI reference
ranges for obesity classification [45].
Blood sampling and analysis
Fasting blood tests will take place at the GP practice be-
tween 08:00 and 11:00. Participants who are not fasted on
arrival will complete the venepuncture on another occasion.
Blood samples will be drawn by the research or practice
nurse from an antecubital vein and dispensed into vacutai-
ner collection tubes (Becton Dickinson, Oxford, UK) con-
taining the anticoagulants ethylenediaminetetraacetic acid
or fluoride oxalate for plasma samples, and serum-
separator tubes for serum samples. Blood samples will be
marked with a project identifier code and participant study
number before being sent to the Royal United Hospital
Bath NHS Trust Clinical Pathology Laboratory. Samples
will be centrifuged at ambient temperature within 6 hours
of collection (3120 g for 10 minutes). Samples will be sepa-
rated and analysed within 24 hours (except for insulin
which was frozen at −20 °C and analysed at a later date).
Serum triglycerides, total and high-density lipoprotein chol-
esterol, plasma glucose, and C-reactive protein will be de-
termined using a Cobas 8000 (Roche Diagnostics Limited,
Burgess Hill, UK). Low-density lipoprotein cholesterol will
be calculated using the Friedewald equation [46]. Insulin
analyses will be undertaken on a Roche E170 analyser
(Roche Diagnostics, Mannheim, Germany). The assay em-
ploys a direct electro-chemiluminescence immunoassay uti-
lising a mouse monoclonal antibody labelled with
ruthenium and a second mouse monoclonal antibody
coupled to paramagnetic particles.
Questionnaire and qualitative measurements
The Psychological Need Satisfaction in Exercise Scale will
be used to measure perceived competence, relatedness and
autonomy [47] while motivational regulations for exercise
will be assessed using the BREQ-2 [48]. Leisure-time phys-
ical activity habit will be measured using a four-item auto-
maticity subscale of the Self-Report Habit Index [49],
vitality using the Subjective Vitality Scale [50] and compe-
tence using the Perceived Competence Scale [51]. In
addition, subscales from the Intrinsic Motivation Inventory
[52, 53] will be adapted to specifically measure the dimen-
sions of exercise-related interest/enjoyment, effort/import-
ance and pressure/tension. Health status and quality of life
will be assessed using the SF-36 Health Survey Question-
naire [54] and the EQ-5D 3 L [55]. In addition, theDepartment of Health’s Life-Stage Segmentation Toolkit
[56] will be used to segment participants factoring in attitu-
dinal and psychographic data (a person’s overall approach
to life, including personality traits, values and beliefs) and
within the context of their social and material
circumstances.
We will conduct focus groups at the end of the trial with
20–30 participants from a subset of the intervention arm to
explore their experiences from participating in the trial and
to seek detailed feedback for the suitability and acceptability
of the intervention components. These focus groups will
specifically focus on the importance of the physical activity
profiles, the usefulness of the meetings, the barriers and fa-
cilitators of change, the dimensions of physical activity that
participants modified and any other lifestyle behaviours in-
fluenced by participation in the trial. We will employ pur-
poseful sampling procedures to capture diverse experiences
of responders and non-responders across different physical
activity dimensions.
Physical activity assessment
Physical activity energy expenditure will be estimated using
a Bodymedia Core monitor (BodyMedia Inc., Pittsburgh,
PA, USA). This is a wireless multisensor device worn over
the triceps muscle that integrates accelerometry and heat-
related measurements (heat flux, galvanic skin response,
skin temperature and near body ambient temperature), and
sex, age, height and body mass to estimate energy expend-
iture using proprietary algorithms (SenseWear® Pro 8.0, al-
gorithm v5.2, BodyMedia Inc., Pittsburgh, PA, USA). The
monitor has rechargeable batteries and can be used to col-
lect and store data for 2 weeks – with data sampled at 1-
minute intervals. Previous research has shown the Bodyme-
dia SenseWear® (BodyMedia Inc., Pittsburgh, PA, USA) de-
vice accurately measures energy expenditure relative to
criterion measures [57–59] and has been increasingly used
to quantify sedentary time, physical activity and energy ex-
penditure in experimental trials [60, 61]. Participants will
be required to wear the monitor for at least 6 days (includ-
ing a Saturday and Sunday) to be included in the analysis
[23], and will be instructed to only remove the device for
showering and water-based activities. A valid day requires
at least 80 % data for a given 24-hour period. As described
previously, minutes spent in the distinct intensity thresh-
olds based on metabolic equivalent cut points and multidi-
mensional health target attainment will be calculated [6].
Data gaps will be assigned estimated basal energy expend-
iture [35].
Sham activity monitoring
A potential threat to any study that measures physical activ-
ity behaviour is confounding due to a Hawthorne effect (i.e.
changes in behaviour that occur simply due to the special
attention afforded by the intervention). In the past, we have
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ity is being observed (e.g. [7]) but, inevitably, this is not an
option in the present study because the intervention group
will become necessarily more aware of their physical ac-
tivity and could potentially change their behaviour dur-
ing specific outcome assessment periods (e.g. for social
desirability). One approach to overcome this threat and
to avoid any short-term changes in behaviour associ-
ated with physical activity outcome assessment is to ex-
tend the perceived assessment window. In order to
achieve this, we will employ the use of a sham physical
activity monitor worn on the wrist in the 1-month prior
to follow-up measurements (in both groups). In most
cases we will employ a genuine sham (i.e. an empty
shell) but at least 5 % of sham monitors will be real
working units (MotionWatch 8, Cambridge Neurotech-
nology Ltd., Cambridge, UK). The motion watch can
record and store data for up to 120 days with a 1-
minute sampling frequency. Participants will be told
that some devices will be recording and others may
not.Trial fidelity
We will include a range of the strategies outlined by the
National Institute of Health Behaviour Change Consortium
to maximize and monitor trial fidelity across the established
five domains of Study Design, Training, Delivery, Receipt,
and Enactment [62]. First, we will implement standardised
training of intervention providers (see Training of the life-
style coaches: intervention and control) and will train more
coaches than needed to protect against dropout. Trial fidel-
ity will be monitored by: selective recording of consultation
meetings; fidelity checklists (administered at the end of
each session); and, provision of formative feedback to
health trainers. Engagement of participants with the on-line
platform will be assessed quantitatively by the number of
occasions that participants logged in to the website. In
addition, adherence to coaching sessions will be assessed by
coach records of the number and format of support ses-
sions delivered.Concomitant medication and usual care
All changes in medications or new diagnoses during
the course of the study will be recorded by the research
nurse either in-clinic or following examination of pa-
tient records at baseline, 3 and 12 months. All relevant
over-the-counter or prescription medication, the generic
name of each medication, dose, frequency and history will
be recorded. In addition, the research nurse will document
any care participants receive in relation to supporting
changes in weight or physical activity throughout the
study.Statistics
Number of participants
Although an exploratory trial, it is prudent and instruct-
ive to conduct a formal sample size estimation. For this
purpose, our specific outcome is mean physical activity
energy expenditure (expressed as PAL). In middle-aged
men [4], the standard deviation for PAL was 0.18 (we
have no reason to suspect a substantially different vari-
ability in women). Our targeted effect size is a difference
between intervention and control arms in the 12-month
change in PAL from baseline to follow-up of 0.07. Based
on our previous data [4], an increase in PAL of that
magnitude would result in an increase of 10 % in the
proportion meeting the minimum physical activity rec-
ommendation of a PAL of 1.6 [63], which we define as
the smallest worthwhile effect [64]. With 2P = 0.05, 90 %
power, and an assumed correlation between baseline and
follow-up values of r = 0.7, the required sample size with
an Analysis of Covariance model [65] is 108 in the inter-
vention and 54 in the control. Allowing for 25 % loss to
follow-up (attrition) results in a final target sample size
of 144 in the intervention group and 72 controls. The
assumed correlation between baseline and follow-up
(the 12-month reliability) is a conservative estimate, as
we are aware of no long-term reliability data using the
best objective measures. Note that we are not, a priori,
attaching primacy to PAL and we will examine multiple
physical activity dimensions. PAL permits a robust sam-
ple size estimate and is clearly important.
Data analysis
Analyses will be undertaken on an intention-to-treat basis.
The statistical analysis plan is for a primary comparison be-
tween intervention and control arms of the 12-month
change in physical activity using an analysis of covariance
model [66], with baseline values as the covariate to control
for chance imbalances at baseline (accounting for any un-
equal variance due to the unequal allocation, and including
the factors used in minimisation [67]). Analysis of inter-
action effects involving age-group or sex will be explora-
tory only and used to inform sample size planning for any
subsequent definitive trial or evaluation. The analysis
adopts a linear mixed model to provide the mean interven-
tion effect together with quantification (as a standard devi-
ation) of the individual participant differences in response
to the intervention (‘treatment heterogeneity’) [68]. Confi-
dence intervals, confidence levels, and magnitude-based in-
ferences will be used to assess the clinical significance of
the effect [64, 69, 70]. The same analysis strategy is applied
to each dimension of physical activity, with due account
taken of multiplicity [71]. In accordance with our sec-
ond objective, for body weight and composition and
metabolic control outcomes we will explore – using
accepted regression-modelling methods – the extent
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in physical activity dimensions. Qualitative data will
be analysed using thematic analysis based on constant
comparison methods [72]. Techniques to enhance de-
pendability and trustworthiness will include the develop-
ment of a detailed coding scheme and coding checking
protocol, cross-tabulation, negative case analysis and re-
spondent validation (both in situ and by inviting feedback
summaries of analysed data) [73].Discussion
It is important that physical activity fulfils its potential
in making an effective contribution towards the success
of public health initiatives. This paper describes the
protocol for the Mi-PACT randomised controlled trial
which aims to modulate physical activity, generate
meaningful weight loss and improve metabolic health in
patients at risk of cardiovascular disease and diabetes
mellitus recruited from primary care. It is increasingly
apparent that there are a variety of dimensions to phys-
ical activity that are independently important and we
need to harness this information to avoid public confu-
sion and disappointment regarding efforts to change
physical activity behaviour. In particular, the marketing
of informational feedback and set of physical activity op-
tions is potentially a key step in supporting increased en-
gagement and sustained lifestyle modifications.
With technological innovation, the capture and provision
of multidimensional physical activity ‘profiles’ is increas-
ingly accurate, precise and scalable. In the present trial, we
will examine whether multidimensional physical activity
feedback from wearable physical activity monitors and self-
monitoring using an online platform can be successfully in-
corporated into existing healthcare provision; and whether
this leads to a meaningful change in physical activity in pa-
tients at risk of chronic disease. We envisage direct poten-
tial application within the context of public health
initiatives (e.g. NHS Health Check). In addition, multidi-
mensional physical activity profiling could become an ad-
junct to other public health strategies in primary practice
(e.g. weight loss or cardiac rehabilitation).Trial status
Enrolment into the study started on 13 May 2014. Re-
cruitment is expected to be completed by 1 June 2015
and follow-up assessment in a further 12 months.Abbreviations
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